Language Selection


Molecular Detection

<<Return to Laboratory

Requisition Forms

Reference Details


Molecular detection of Ehrlichia chaffeensis in clinical specimens.

Test Category:
Molecular Detection and Genotyping
Ehrlichia chaffeensis
Illnesses and Diseases:
  • Ehrlichiosis

Whole blood or buffy coat are recommended. Cerebrospinal fluid (CSF) from patients whose clinical condition suggests meningitis are acceptable. Minimum required volumes are as follows:

  • Whole blood - 5.0 mL.
  • Buffy coat – 0.5 mL
  • CSF – 0.5 mL
Collection Method:

Collect blood in EDTA tubes.  Avoid heparin.  Do not centrifuge. Aseptically collect buffy coat or CSF into sterile, leak-proof container made of freeze-thaw and shatter-resistant plastic, without additives.

Specimen Processing, Storage and Shipping:

Store specimens refrigerated up to 5 days and ship with freezer packs. If > 5 days, store at – 20 °C and ship on dry ice.

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.


Patient Criteria:

Appropriate clinical symptoms with known exposure to Amblyomma americanum (Lone Star) tick in Canada OR travel the United States. The symptoms of infection with Ehrlichia chaffeensis usually develop 1-2 weeks after being bitten by an infected tick. Symptoms may include fever, headache, chills, malaise, myalgia, nausea / vomiting / diarrhea, confusion, conjunctival injection and rash.

Accompanying Documentation:

Completed Requisition for Molecular Testing for Selected Zoonotic Agents. If possible, include the clinical history and lab results performed at local or provincial laboratories.


Specimens may be subject to rejection if they are not the appropriate sample type, have insufficient volume, or not accompanied by relevant patient information and travel history. This test is performed for investigational purposes.

Methods and Interpretation of Results:

Extracted DNA is screened by an in-house real-time PCR assay specific for E. chaffeensis. If positive by real-time PCR, samples are subject to confirmation testing tested by conventional PCR and sequencing for E. chaffeensis. 

Initiation of antibiotic treatment prior to testing may result in decreased bacterial genome which will affect the outcome of PCR testing.

Turnaround Time:

21 calendar days.

Phone #: (204) 789-6068
Fax: (204) 789-2082
  1. Loftis, A., D., Massung, R. F., Levin, M., L. 2003. Quantitative real-time PCR assay for detection of Ehrlichia chaffeensis. J. Clin. Microbiol. 41(8):3870-3872.
  2. Standaert, S.M., Yu, T., Scott, M.A., et al. 2000. Primary Isolation of Ehrlichia chaffeensis from patients with febrile illnesses: Clinical and molecular characteristics. J. Inf. Dis. 181:1082-1088.
Fact Sheets:
Related Information: